Home › Clinical Tools › AF cardioversion anticoagulation

⚡ Anticoagulation Management for AF Cardioversion

UseUse to decide pre-cardioversion anticoagulation (or TEE) and the mandatory post-cardioversion course, separat…

Loading calculator…

SourceVan Gelder IC, et al. 2024 ESC Guidelines for the management of atrial fibrillation. Eur Heart J 20…

Runs locally in your browser (no PHI uploaded). For licensed clinicians — not a substitute for clinical judgement.
Stored on this device for revisit reminders

This-shift next steps

After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.

Score + version; reference only — not a substitute for care · no HIS write

Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.

Methodology · worked example, guidelines & full notes
Clinical takeaway

Anticoagulation continues at least 4 weeks after cardioversion regardless of duration or stroke risk, because of thrombus risk during atrial stunning. (original synthesis · not guideline verbatim)

When to use

Use to decide pre-cardioversion anticoagulation (or TEE) and the mandatory post-cardioversion course, separating unstable patients who need immediate cardioversion.

How it works

Unstable → immediate cardioversion, anticoagulate ASAP. Definite < 24 h → early cardioversion possible without 3 weeks of anticoagulation (2024 ESC/EACTS). ≥ 24 h/uncertain → anticoagulate ≥ 3 weeks or TEE-exclude thrombus. All → ≥ 4 weeks after cardioversion.

Key points

  • Anticoagulation continues at least 4 weeks after cardioversion regardless of duration or stroke risk, because of thrombus risk during atrial stunning. (original synthesis · not guideline verbatim)
  • Long-term anticoagulation is decided by CHA₂DS₂-VASc, not by whether sinus rhythm was achieved.
  • A left-atrial-appendage thrombus on TEE defers cardioversion for 4–12 weeks of anticoagulation.

References

Worked calculation

The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.

AF duration< 24 hours (definite)
Hemodynamically unstableNo

→Pre-cardioversion anticoagulation strategyDefinite < 24 h: early cardioversion possible

  • Peri-cardioversion:Definite duration < 24 h: early cardioversion without 3 weeks of prior anticoagulation is possible (2024 ESC/EACTS; PMC11666470 commentary). Continue anticoagulation at least 4 weeks after cardioversion
  • After cardioversion:Regardless of sinus-rhythm maintenance or stroke risk, anticoagulate at least 4 weeks after cardioversion (thrombus risk during atrial stunning)
  • Long-term anticoagulation:Whether to anticoagulate long-term is decided by CHA₂DS₂-VASc stroke risk (see AF anticoagulation tool), not by whether cardioversion was done or sinus rhythm achieved
AF duration≥ 24 hours or uncertain duration
Hemodynamically unstableYes

→StrategyImmediate cardioversion (no delay)

  • Cardioversion:Hemodynamically unstable (hypotension/myocardial ischemia/acute HF/shock): immediate synchronized cardioversion, not delayed for anticoagulation
  • Anticoagulation:Start anticoagulation as soon as possible (UFH/LMWH or NOAC); continue at least 4 weeks after cardioversion
  • Long-term:Then decide long-term anticoagulation by CHA₂DS₂-VASc (see AF anticoagulation tool)
Verification & sources · governance
FAQ

Frequently asked questions

What are the limits and cautions when using Anticoagulation Management for AF Cardioversion?
For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
Does Anticoagulation Management for AF Cardioversion upload patient data? Where is it calculated?
Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
How is Anticoagulation Management for AF Cardioversion calculated in practice? Can you show a worked example?
Inputs: AF duration < 24 hours (definite), Hemodynamically unstable No → Result: Pre-cardioversion anticoagulation strategy Definite < 24 h: early cardioversion possible(Peri-cardioversion: Definite duration < 24 h: early cardioversion without 3 weeks of prior anticoagulation is possible (2024 ESC/EACTS; PMC11666470 commentary). Continue anticoagulation at least 4 weeks after cardioversion, After cardioversion: Regardless of sinus-rhythm maintenance or stroke risk, anticoagulate at least 4 weeks after cardioversion (thrombus risk during atrial stunning), Long-term anticoagulation: Whether to anticoagulate long-term is decided by CHA₂DS₂-VASc stroke risk (see AF anticoagulation tool), not by whether cardioversion was done or sinus rhythm achieved) Inputs: AF duration ≥ 24 hours or uncertain duration, Hemodynamically unstable Yes → Result: Strategy Immediate cardioversion (no delay)(Cardioversion: Hemodynamically unstable (hypotension/myocardial ischemia/acute HF/shock): immediate synchronized cardioversion, not delayed for anticoagulation, Anticoagulation: Start anticoagulation as soon as possible (UFH/LMWH or NOAC); continue at least 4 weeks after cardioversion, Long-term: Then decide long-term anticoagulation by CHA₂DS₂-VASc (see AF anticoagulation tool))
Related tools